Our basic and clinical research has contributed to the development of pharmaceuticals that has included pivotal treatments for dry eyes, ocular herpes, and corneal ulcers. Read More
Kidney Damage in First Responders Linked to September 11
November 9, 2013 - For the first time, researchers have linked high levels of inhaled particulate matter by first responders at Ground Zero to kidney damage.
Mount Sinai Heart Launches Clinical Trial to Test if Coronary Stent Patients Can Avoid Taking Aspirin
August 11, 2015 - International clinical trial TWILIGHT to test the safety and effectiveness of treating coronary stent patients with the anti-clotting medication ticagrelor instead of combining it with aspirin.